Literature DB >> 29669717

Weighing the risks of valproate in women who could become pregnant.

Heather Angus-Leppan1,2,3, Rebecca S N Liu4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29669717     DOI: 10.1136/bmj.k1596

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.

Authors:  Linda J Stephen; Martin J Brodie
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

2.  Valproate and the Pregnancy Prevention Programme: exceptional circumstances.

Authors:  Lance V Watkins; Hannah R Cock; Heather Angus-Leppan; Rohit Shankar
Journal:  Br J Gen Pract       Date:  2019-04       Impact factor: 5.386

3.  Adverse events reported for Mirena levonorgestrel-releasing intrauterine device in France and impact of media coverage.

Authors:  Claire Langlade; Amandine Gouverneur; Pauline Bosco-Lévy; Aurore Gouraud; Marie-Christine Pérault-Pochat; Johana Béné; Ghada Miremont-Salamé; Antoine Pariente
Journal:  Br J Clin Pharmacol       Date:  2019-07-31       Impact factor: 4.335

4.  Valproate MHRA Guidance: Limitations and Opportunities.

Authors:  Lance Watkins; Hannah Cock; Heather Angus-Leppan; Kim Morley; Mike Wilcock; Rohit Shankar
Journal:  Front Neurol       Date:  2019-02-20       Impact factor: 4.003

5.  Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.

Authors:  Mariangela Gaudio; Emmanouela Konstantara; Mark Joy; Jeremy van Vlymen; Simon de Lusignan
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-27       Impact factor: 3.007

6.  Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs.

Authors:  Emily A F Holmes; Catrin Plumpton; Gus A Baker; Ann Jacoby; Adele Ring; Paula Williamson; Anthony Marson; Dyfrig A Hughes
Journal:  Clin Pharmacol Ther       Date:  2018-10-25       Impact factor: 6.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.